Brunei Darussalam vs Croatia: Prevalence rate of hypertension in women aged 30-79
Brunei Darussalam
45.6
in 2019
Croatia
45.3
in 2019
Brunei Darussalam rank
17th
Croatia rank
19th
Prevalence rate of hypertension in women aged 30-79 over time
- Brunei Darussalam
- Croatia
How they compare
Brunei Darussalam currently reports 45.6 against 45.3 in Croatia, a difference of 0.3.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Croatia ahead.
Brunei Darussalam ranks 17th and Croatia ranks 19th of 195 countries.
Croatia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brunei Darussalam | Croatia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 36.93 | 45.7 | 8.77 | Croatia |
| 2000s | 40.45 | 43.47 | 3.02 | Croatia |
| 2010s | 44.27 | 44.88 | 0.61 | Croatia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Brunei Darussalam or Croatia?
- Brunei Darussalam, at 45.6 against 45.3 in Croatia as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Brunei Darussalam and Croatia?
- 0.3, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and Croatia?
- 30 years are reported by both, from 1990 to 2019.
- How do Brunei Darussalam and Croatia rank globally for prevalence rate of hypertension in women aged 30-79?
- Brunei Darussalam ranks 17th and Croatia ranks 19th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.